COVID-19 Supplement #4 for CoVPN 5002 Prevalence Study

NIH RePORTER · NIH · UM1 · $2,229,401 · view on reporter.nih.gov ↗

Abstract

Saint Louis University (SLU) seeks to expand its service to the Vaccine and Treatment Evaluation Unit (VTEU) network providing resources and expertise to help the network achieve its objectives of evaluating vaccines, preventive biologics, therapeutics and diagnostics for COVID-19.

Key facts

NIH application ID
10249622
Project number
3UM1AI148685-02S2
Recipient
SAINT LOUIS UNIVERSITY
Principal Investigator
Daniel F. Hoft
Activity code
UM1
Funding institute
NIH
Fiscal year
2021
Award amount
$2,229,401
Award type
3
Project period
2020-12-21 → 2021-11-30